Stereotaxis, Inc.
STXS · Electromedical & Electrotherapeutic Apparatus · 97.7M shares · +4%/yr ↑ dilution · EDGAR filings ↗
Reference price $2.18 · est. market cap ~$213M — last insider purchase, 2025-11-17 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D47Stereotaxis — robotic-cardiology device maker running losses.
Strengths
- Revenue +20%; differentiated magnetic-navigation platform
Risks
- Operating margin -68%; ROE -161% (31st pct)
- Capital-equipment sales cyclicality; cash needs
Notable findings
- Net lossNet loss (net margin -66.8%)
- Revenue declineRevenue -27.2% YoY
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
52.7%
Operating margin
-68.3%
Net margin
-66.8%
Return on equity
-160.5%
Return on assets
-41.4%
Revenue growth (QoQ)
-27.2%
Current ratio
1.5×
Tangible book value
$3M
Cash & investments
$13M
Stock comp / revenue
30.4%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-01-02 | Menawat Arun Swarup | Grant | 47K | — |
| 2026-01-02 | Benfer David | Grant | 47K | — |
| 2026-01-02 | Fischel Nathan | Grant | 47K | — |
| 2026-01-02 | Curet Myriam | Grant | 47K | — |
| 2026-01-02 | Levin Ross B | Grant | 47K | — |
| 2026-01-02 | SHAMIR NACHUM | Grant | 47K | — |
| 2025-11-17 | Isaac Paul J | Buy | 10K | $2.18 |
| 2025-11-14 | Isaac Paul J | Buy | 20K | $2.24 |
| 2025-07-01 | Benfer David | Grant | 44K | — |
| 2025-07-01 | Menawat Arun Swarup | Grant | 44K | — |
| 2025-07-01 | Fischel Nathan | Grant | 44K | — |
| 2025-07-01 | Levin Ross B | Grant | 44K | — |
| 2025-07-01 | Curet Myriam | Grant | 44K | — |
| 2025-07-01 | SHAMIR NACHUM | Grant | 44K | — |
| 2025-03-10 | Isaac Paul J | Buy | 38K | $1.81 |
| 2025-03-07 | Isaac Paul J | Buy | 1.5K | $1.79 |
| 2025-03-06 | Isaac Paul J | Buy | 23K | $1.81 |
| 2025-01-02 | Fischel Nathan | Grant | 56K | — |
| 2025-01-02 | Benfer David | Grant | 56K | — |
| 2025-01-02 | Curet Myriam | Grant | 56K | — |
| 2025-01-02 | SHAMIR NACHUM | Grant | 46K | — |
| 2025-01-02 | Levin Ross B | Grant | 56K | — |
| 2025-01-02 | Menawat Arun Swarup | Grant | 56K | — |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-05-15 | Shareholder vote | filing ↗ |
| 2026-05-12 | ResultsExhibits | filing ↗ |
| 2026-04-15 | Material agreement3.02Reg FDExhibits | filing ↗ |
| 2026-03-09 | ResultsExhibits | filing ↗ |
| 2025-11-12 | ResultsExhibits | filing ↗ |
| 2025-08-29 | Material agreementExhibits | filing ↗ |
| 2025-08-07 | ResultsExhibits | filing ↗ |
| 2025-07-17 | Material agreementReg FDExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-05-15 | 2026-05-14 | 0001493152-26-023654 ↗ |
| 10-Q | 2026-05-13 | 2026-03-31 | 0001493152-26-022697 ↗ |
| 8-K | 2026-05-12 | 2026-05-12 | 0001493152-26-022488 ↗ |
| 8-K | 2026-04-15 | 2026-04-14 | 0001493152-26-016685 ↗ |
| 10-K/A | 2026-04-03 | 2025-12-31 | 0001493152-26-015172 ↗ |
| 10-K | 2026-03-12 | 2025-12-31 | 0001493152-26-009881 ↗ |
| 8-K | 2026-03-09 | 2026-03-09 | 0001493152-26-009366 ↗ |
| 10-Q | 2025-11-12 | 2025-09-30 | 0001493152-25-021881 ↗ |
| 8-K | 2025-11-12 | 2025-11-11 | 0001493152-25-021772 ↗ |
| 8-K | 2025-08-29 | 2025-08-29 | 0001641172-25-026031 ↗ |
| 10-Q | 2025-08-13 | 2025-06-30 | 0001641172-25-023417 ↗ |
| 8-K | 2025-08-07 | 2025-08-07 | 0001641172-25-022580 ↗ |